title: Undocumented Immigrants Face a Unique Set of Risks from Tuberculosis Treatment: Is This Just?
authors.affiliation: Assistant professor of population health and medicine at New York University School of Medicine and a primary care physician at Bellevue Hospital Center in New York City.
authors.forename: Kelly A
authors.initials: KA
authors.lastname: Kyanko
authors.affiliation: Instructor of medicine in the Department of Medicine within the Division of Pulmonary, Critical Care, and Sleep Medicine at New York University School of Medicine in New York City.
authors.forename: Jun-Chieh James
authors.initials: JC
authors.lastname: Tsay
authors.affiliation: Assistant professor of pediatrics at the PolicyLab at the Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania in Philadelphia.
authors.forename: Katherine
authors.initials: K
authors.lastname: Yun
authors.affiliation: Director of applied bioethics at New York University School of Professional Studies and a faculty affiliate of the Division of Medical Ethics at New York University Langone Medical Center in New York City.
authors.forename: Brendan
authors.initials: B
authors.lastname: Parent
mesh_terms: D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D026689:Ethical Analysis; D006297:Health Services Accessibility / Q000941:ethics / Q000331:legislation & jurisprudence; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000009:adverse effects; D055985:Latent Tuberculosis / Q000188:drug therapy*; D017114:Liver Failure, Acute / Q000139:chemically induced*; D016031:Liver Transplantation; D017057:Medically Uninsured; D011203:Poverty; D012306:Risk; D012935:Social Justice; D000069756:Undocumented Immigrants; D014481:United States
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid